![](/img/cover-not-exists.png)
A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils
Marks-Konczalik, Joanna, Costa, Maria, Robertson, Jon, McKie, Elizabeth, Yang, Shuying, Pascoe, StevenVolume:
109
Language:
english
Journal:
Respiratory Medicine
DOI:
10.1016/j.rmed.2015.05.003
Date:
July, 2015
File:
PDF, 585 KB
english, 2015